Related by context. All words. (Click for frequent words.) 67 Erythropoietic therapies may 65 severe hypoglycemic 65 cerebrovascular adverse 64 KIF6 carriers 64 acute coronary 64 thrombotic events 64 hematologic adverse 63 colorectal adenoma 63 periprocedural 63 prolonged QT interval 62 atherosclerotic cardiovascular 62 angiotensin converting enzyme inhibitor 62 myocardial infarction stroke 62 serious cardiovascular thrombotic 62 serum calcium levels 62 nicardipine 62 ischemic cardiovascular 62 β blockers 62 reinfarction 62 IIIa inhibitor 62 platelet reactivity 62 β blocker 62 ATACAND 62 thromboembolic 62 fibrinolytic 61 unstable angina pectoris 61 thromboembolic events 61 agents ESAs 61 myopathy rhabdomyolysis 61 Treatment emergent adverse 61 aspirin clopidogrel 61 paclitaxel eluting stents 61 potassium sparing diuretics 61 ocular adverse 61 simvastatin ezetimibe 61 endometriosis ovarian cysts 61 discontinuations due 60 Lp PLA 2 60 tumor lysis syndrome 60 EXJADE 60 silent ischemia 60 antiplatelet medications 60 serum creatinine levels 60 resuscitated cardiac arrest 60 tirofiban 60 recurrent VTE 60 cardiovascular ischemic 60 arterial thromboembolic 60 clopidogrel 60 nephrotoxicity 60 lipid lowering drugs 60 Major Adverse Cardiac 60 myocardial infarction MI 60 VIIBRYD 60 benazepril 60 hematologic toxicity 60 deep venous thromboses 60 torsades de pointes 60 prednisone prednisolone 60 fatal myocardial infarction 60 hematological adverse 60 noncardiovascular mortality 60 VT VF 60 ACTOplus met XR 60 lispro 60 elevated creatinine 59 verapamil 59 CVD mortality 59 neutrophil counts 59 angiotensin converting enzyme inhibitors 59 left ventricular dysfunction 59 arterial calcification 59 ventricular tachycardia VT 59 nocturnal hypoglycaemia 59 recurrent ischemia 59 hemorrhagic complications 59 postoperative mortality 59 Pioglitazone 59 FASLODEX 59 labetalol 59 CYP#A# substrate 59 tamoxifen Nolvadex ® 59 renal dysfunction 59 NPH insulin 59 postoperative AF 59 ischemic complications 59 hyperkalemia 59 atherothrombotic 59 ABCB1 59 ischemia driven 59 thiazide diuretics 59 cardiovascular thrombotic 59 HMG CoA reductase inhibitors 59 sirolimus eluting stents 59 thromboembolism 59 flutamide 58 unstable angina UA 58 APTIVUS r 58 severe hypersensitivity reactions 58 ipsilateral stroke 58 antihypertensive therapy 58 angiotensin II receptor blockers 58 antiarrhythmic drug 58 dose atorvastatin 58 autoantibody levels 58 severe neutropenia 58 Ramipril 58 intima media thickness 58 serum phosphorous 58 carotid IMT 58 nonfatal stroke 58 insulin detemir 58 glulisine 58 thrombo embolic 58 serum phosphate 58 torsade de pointes 58 irbesartan 58 macrovascular events 58 triglyceride concentrations 58 Acute Coronary Syndrome 58 LOVENOX R 58 TEAEs 58 nonfatal myocardial infarction 58 pravastatin Pravachol 58 plasma glucose levels 58 cerebrovascular events 58 conjugated equine estrogen 58 leucopenia 58 thienopyridine 58 anthracycline taxane 58 diastolic BP 58 serum urate 58 ventricular tachyarrhythmia 58 Hyperlipidemia 58 SHBG levels 58 endometrial hyperplasia 58 Platinol ® cisplatin 58 anthracycline containing 58 fibrinolysis 58 GnRH agonist 58 Kaplan Meier estimates 58 abdominal adiposity 58 liver enzymes ALT 58 lipid lowering medications 58 angina pectoris 58 lipid parameters 58 hormone receptor negative 58 Cypher Stent 58 letrozole Femara 58 IOP lowering 58 EFFEXOR XR 58 serum PTH 58 neutropenia dehydration dyspnea 58 Drug eluting stent 58 nonaspirin 58 coronary revascularization 58 metformin accumulation 58 Tasigna prolongs 58 terfenadine 58 antiplatelet drugs 57 oral antidiabetic medication 57 ramipril 57 Events MACE 57 angiographic restenosis 57 dosing frequency 57 fosamprenavir 57 ULORIC 57 aspirin heparin 57 gemfibrozil 57 abciximab 57 hypoglycemic events 57 atorvastatin #mg 57 LV dysfunction 57 NATRECOR R 57 atherothrombotic events 57 nephrotoxic 57 ST Segment Elevation 57 beta blocker therapy 57 intensive lipid lowering 57 Hypotension 57 ARCOXIA 57 concomitant medications 57 serum ALT 57 NATRECOR ® 57 variceal bleeding 57 calcium antagonists 57 receiving VELCADE 57 hallucinations dyskinesia 57 Ischemic 57 serum potassium 57 ICD shocks 57 oral hypoglycemic agents 57 GP IIb IIIa inhibitors 57 nadolol 57 everolimus eluting stents 57 PLX STROKE targeting 57 QTc intervals 57 thiazide diuretic 57 LYSTEDA 57 LDL cholesterol concentrations 57 nevirapine Viramune 57 dalteparin 57 induce orthostatic hypotension 57 advanced adenomas 57 inhaled budesonide 57 TNF antagonist 57 TAXUS Stent 57 venlafaxine Effexor 57 acarbose 57 pamidronate 57 binary restenosis 57 MEVACOR 57 myocardial infarction ventricular fibrillation 57 thrombogenic 57 nonvertebral fractures 57 pyrexia mucositis sepsis febrile 57 ACEIs 57 achieved ACR# 57 estramustine 57 insulin secretagogue 57 definite stent thrombosis 57 serum bicarbonate 57 APTIVUS ritonavir 57 Elitek 57 Exacerbations 57 coadministration 57 ARIXTRA 57 adrenal suppression 57 non valvular atrial 57 cerebral ischemic 57 antihypertensive agents 57 aminotransferases 57 maximally tolerated 57 arterial thromboembolic events 57 MULTAQ 57 microvascular disease 57 locoregional recurrence 57 Lp PLA2 57 prolactin levels 57 events thrombocytopenia neutropenia 57 loop diuretics 57 serum triglycerides 57 venous thromboembolic 57 Drospirenone 57 cardiovascular morbidity 57 antiangiogenic agents 57 #mm Hg 57 mycophenolate mofetil 57 pulmonary exacerbations 57 renal toxicity 57 thrombus aspiration 57 serum calcium 57 clevidipine 57 prospectively stratified 57 anticoagulant warfarin 57 protease inhibitors PIs 57 homocysteine concentrations 57 thrombotic 57 systemic hypotension 57 LVSD 57 Helicobacter pylori eradication 57 carotid plaque 56 malignancy HCM 56 systemic embolism 56 TMP SMX 56 glycosylated hemoglobin levels 56 coagulation abnormalities 56 oral antidiabetic drugs 56 nonfatal MI 56 Severe hypersensitivity reactions 56 intravenous bisphosphonates 56 Tekamlo 56 tHcy 56 albumin excretion rate 56 dapagliflozin plus 56 coronary revascularization procedures 56 triglyceride concentration 56 elevated triglyceride levels 56 transaminase elevations 56 thromboembolic disorders 56 thrombolytic agents 56 endometrial thickness 56 serum aminotransferase levels 56 macrovascular 56 Infusion Reactions Severe 56 Thal Dex 56 GI bleeds 56 erythropoietic 56 spontaneous preterm delivery 56 STRIDE PD 56 causes myocardial ischemic 56 apnea hypopnea 56 inflammatory biomarkers 56 intensive statin therapy 56 certolizumab 56 infusional 56 fasting glucose levels 56 Prilosec omeprazole 56 warfarin erythromycin 56 isoproterenol 56 gemcitabine Gemzar 56 platelet inhibitor 56 epoetin alpha 56 Glucophage metformin 56 steroid dexamethasone 56 dipyridamole plus 56 paroxetine sertraline 56 cardiovascular calcification 56 AST ALT 56 lipid lowering agents 56 neutropenic patients 56 antiplatelet agent 56 perindopril 56 desvenlafaxine succinate 56 IIIa inhibitors 56 alpha interferons 56 salpingo oophorectomy 56 plasma lipids 56 CsA 56 angiotensin converting enzyme 56 neointimal hyperplasia 56 sotalol 56 pyridostigmine 56 plasma glucose 56 hypercholesterolaemia 56 fluvastatin Lescol 56 avosentan 56 LEXIVA 56 hypercalcemia 56 A1c levels 56 severe exacerbations 56 moderate renal impairment 56 febrile neutropenia 56 lipid elevations 56 ischemic cerebrovascular 56 nonischemic 56 beta blockers ACE inhibitors 56 liver transaminases 56 NNRTI resistant virus 56 myocardial infarction 56 nonhematologic adverse reactions 56 severe hypoglycemia 56 bleeding ulceration 56 tibolone 56 Unstable Angina 56 Natalizumab 56 eptifibatide 56 XIENCE V demonstrated 56 Known hypersensitivity 56 thiazolidinedione TZD 56 TAXUS Express Stent 56 neuropsychiatric adverse 56 aplindore 56 hematological parameters 56 TDF FTC 56 potent CYP#A# inhibitors 56 acute ischemic 56 adiponectin levels 56 androgen deprivation 56 AGGRASTAT R tirofiban hydrochloride 56 extrapyramidal symptoms 56 BENICAR HCT 56 IXEMPRA 56 NSTEMI 56 QTc prolongation 56 baseline LDH 56 hemodilution 56 Celecoxib APC trial 56 thrombotic complications 56 hypotensive 56 platelet activation 56 asymptomatic carotid stenosis 56 candesartan cilexetil 56 ARB telmisartan 56 Stent thrombosis 56 serum concentrations 56 thromboembolic complications 56 potentially hepatotoxic 56 thyrotropin levels 56 recurrent coronary 56 biologic DMARD 56 Mg Uk 56 omeprazole Prilosec 56 atherothrombotic disease 56 angiotensin receptor blocker 56 pioglitazone HCl 56 renal insufficiency 56 corticosteroid dose 56 alfuzosin 56 Diovan HCT 56 antiangiogenic therapy 56 gastric pH 56 metformin sulfonylureas 56 concomitant medication 56 didanosine associated 56 FIRMAGON 56 receiving prophylactic anticoagulation 56 AGGRASTAT ® tirofiban hydrochloride 56 recurrent glioblastoma multiforme 56 HMG CoA reductase inhibitor 56 hsCRP levels 56 Carvedilol 56 symptom exacerbation 56 nondiabetic patients 56 hyperphenylalaninemia HPA due 55 antithrombotic therapies 55 venous thromboembolic events 55 Fibrates 55 prednisone prednisolone plus 55 Newly Diagnosed Multiple Myeloma 55 metformin sulfonylurea 55 See CLINICAL PHARMACOLOGY 55 ibandronate 55 syncopal 55 HBeAg seroconversion 55 coinfected patients 55 ACTOS ® 55 plasma triglycerides 55 intracerebral haemorrhage 55 virologic failure 55 VAPRISOL 55 Glimepiride 55 mixed hyperlipidemia 55 PSADT 55 Avandia Actos 55 myocardial infarctions 55 insulin sensitizing 55 lowering blood glucose 55 transferrin saturation 55 antiandrogen 55 elevated LDH 55 fluvastatin 55 rebleeding 55 Unstable angina 55 ACE inhibitor ramipril 55 ribavirin therapy 55 ventricular fibrillation VF 55 Multidrug 55 cyclophosphamide methotrexate 55 papillary renal cell carcinoma 55 idraparinux 55 corticosteroid therapy 55 sulfonylurea metformin 55 doxorubicin docetaxel 55 Stent Thrombosis 55 mammographic density 55 Elevated triglycerides 55 symptomatic hyponatremia 55 IFN beta 55 Tarceva TM 55 thromboembolic disease 55 sUA 55 intestinal permeability 55 glycated hemoglobin levels 55 androgen suppression 55 dose ritonavir 55 recurrent DVT 55 contrast induced nephropathy 55 epirubicin 55 Renal dysfunction 55 troponin T 55 MYLOTARG 55 gefitinib Iressa 55 serum lipid 55 Atherosclerotic 55 urate lowering 55 treatment emergent adverse 55 improves insulin sensitivity 55 ventricular arrhythmia 55 DU #b 55 subclinical hypothyroidism 55 Neoadjuvant 55 stented vessel 55 echocardiographic parameters 55 Warfarin Coumadin 55 Procoralan 55 ejection fractions 55 symptomatic VTE 55 dose corticosteroids 55 acute decompensation 55 QTc interval 55 FOSRENOL ® 55 paricalcitol 55 levodopa therapy 55 plasma concentrations 55 VTEs 55 dose statin therapy 55 tardive dyskinesia TD 55 lactate dehydrogenase LDH 55 anticlotting drugs 55 neoadjuvant 55 Cardiotoxicity 55 Torsades de Pointes 55 myocardial ischemia 55 ALT flares 55 COPD exacerbations 55 left ventricular hypertrophy 55 CYP#D# inhibitor 55 Serious adverse reactions 55 upper gastrointestinal bleeding 55 multivessel disease 55 infarction NSTEMI 55 #.#/#.# mmHg [001] 55 ABC/3TC 55 serum estradiol 55 repeat revascularization 55 paroxetine Paxil 55 fluticasone propionate FP 55 CRT ICD 55 carotid endarterectomy CEA 55 CNS systemic embolism 55 preoperative chemotherapy 55 adverse cytogenetics 55 carotid revascularization 55 xanthine oxidase inhibitor 55 valsartan 55 metastatic malignant 55 clopidogrel Plavix 55 uncertainties materialize Shire 55 Perindopril 55 relapsed MM 55 angina chest 55 lumbar spine BMD 55 lenalidomide dexamethasone 55 COREG 55 inhaled glucocorticoids 55 Thalomid ® 55 rosuvastatin #mg 55 PSA nadir 55 QTc 55 PRADAXA 55 thienopyridines 55 laboratory abnormalities 55 cisplatin gemcitabine 55 blood glucose concentrations 55 haematologic 55 clodronate 55 LANTUS R 55 Secondary endpoints include 55 intima media thickness IMT 55 cardiac resynchronisation therapy 55 atrioventricular block 55 intracranial hemorrhage ICH 55 Combination therapy 55 rFVIIa 55 serum uric acid 55 aspartate aminotransferase AST 55 hypercholesterolemic patients 55 baseline HbA1c 55 HER2 overexpression 55 circulating EPCs 55 Lipitor #mg 55 antithrombotic therapy 55 bezafibrate 55 evaluating mipomersen 55 Bivalirudin 55 multivariate adjustment 55 aldosterone antagonists 55 atherosclerotic renal artery stenosis 55 systolic BP 55 AZT zidovudine Retrovir 55 uric acid lowering 55 Severe hypoglycemia 55 aspartate aminotransferase 55 Retrograde ejaculation 55 oxycodone CR 55 nocturnal hypoglycemia 55 recurrent venous thromboembolism 55 QT prolongation 55 Acute Coronary Syndromes 55 Vertebral Fractures 55 biochemical relapse 55 transaminases 55 bolus dose 55 hepatic enzymes 55 MS relapses 55 anticholinergic agents 55 coronary vascular 55 HIV HCV coinfected 55 nonsignificant 55 cardiac contractility 55 elevated LDL cholesterol 55 triacylglycerol concentrations 55 unfractionated heparin UFH 55 cardiovascular disease hypertension 54 NYHA Class II 54 ß blockers 54 telmisartan 54 hormone therapy estrogen 54 distal colon cancer 54 spontaneous preterm birth 54 Losartan 54 cerebrovascular accident 54 Hypersensitivity reactions 54 proliferative diabetic retinopathy 54 undergoing coronary angiography 54 MACCE 54 PREZISTA rtv 54 RISPERDAL ® 54 DES implantation 54 CRESTOR #mg 54 inhaled iloprost 54 interferon IFN 54 shorter telomere length 54 serum homocysteine 54 elevated fasting glucose 54 glycosylated hemoglobin HbA1c 54 polyp recurrence 54 resynchronization therapy 54 serum phosphorus 54 Toxicities 54 5-FU/LV 54 annualized relapse 54 breast endometrial 54 glycoprotein IIb IIIa inhibitor 54 XIENCE V PROMUS Stent 54 deferiprone 54 macrovascular disease 54 GnRH agonists 54 serum triglyceride levels 54 microvascular complications 54 Posaconazole 54 Aspartate 54 Paliperidone 54 ST elevation myocardial 54 atherosclerotic disease 54 interferon alfa 2b 54 myelosuppression 54 rs# [004] 54 decitabine 54 x ULN 54 antidiabetic drugs 54 postintervention 54 confirmed thrombotic cardiovascular 54 Ranolazine 54 sustained ventricular tachycardia 54 primary hypercholesterolemia 54 adiponectin concentrations 54 lumiracoxib 54 SREs 54 apolipoprotein E4 54 bivalirudin 54 biphasic insulin aspart 54 Myocardial infarction 54 hemoglobin A1c HbA1c 54 ARCALYST ® 54 symptomatic intracranial 54 Abciximab 54 lipid lowering therapy 54 indinavir 54 CI #.#-#.# [001] 54 impaired hepatic 54 #.#mg/dL 54 FOLFIRI 54 antianginal 54 hypereosinophilic syndrome 54 radiotherapy RT 54 DAPT 54 Pegylated Liposomal Doxorubicin 54 subcutaneous insulin 54 venous thromboembolic disease 54 antioxidant supplementation 54 3TC lamivudine Epivir 54 dosage regimens 54 mild hepatic impairment 54 UACR 54 node metastases 54 hypomagnesemia 54 revascularizations 54 glomerular filtration 54 severe hypoglycaemia 54 Thrombin Receptor Antagonist 54 thrombocytopenic 54 symptomatic intracranial hemorrhage 54 octreotide LAR 54 OADs 54 fluticasone salmeterol 54 ritonavir boosted 54 #mg/m# [001] 54 bioavailable testosterone 54 angiotensin converting enzyme ACE 54 TNF blocker therapy 54 stent thromboses 54 liver metastasis 54 secondary hyperparathyroidism 54 administered erythropoiesis stimulating 54 CIMZIA ™ 54 ventricular tachyarrhythmias 54 quetiapine XR 54 Nifedipine 54 Dasatinib 54 albuminuria 54 RAS blockers 54 leukotriene pathway 54 Adenoscan 54 COPD exacerbation 54 systolic hypertension 54 JAK2 enzyme 54 HbA 1c levels 54 olmesartan 54 zoledronic acid 54 nasopharyngitis headache 54 Neulasta ® 54 RBP4 levels 54 postprandial insulin 54 fondaparinux 54 anticoagulation 54 VEGF inhibitors 54 primidone 54 antiretroviral naive 54 ACCORD Lipid 54 weekly subcutaneous injections 54 antihypertensive drugs 54 AML MDS 54 CYT# potent vascular disrupting 54 serum glucose 54 esomeprazole Nexium 54 CHD CVD 54 neovascular 54 zoledronic acid Reclast 54 Abbott Trilipix 54 Arrhythmias 54 angiotensin receptor blocker ARB 54 XELOX 54 stroke myocardial infarction 54 skin sterol 54 tinidazole 54 Hematologic 54 thrombus formation 54 urate levels 54 PROCRIT ® 54 IELT 54 revascularization procedures 54 severe renal impairment 54 Restenosis 54 plus medroxyprogesterone acetate 54 Intravitreal 54 CK # plasma concentrations 54 headache nasopharyngitis 54 parecoxib 54 angiotensin receptor blockers 54 adipogenic 54 sFlt 1 54 antithrombotic agent 54 elevated plasma concentrations 54 dose colchicine 54 anthracycline chemotherapy 54 cerebral microbleeds 54 anticoagulants blood thinners 54 cinacalcet 54 pulmonary exacerbation 54 Febrile neutropenia 54 ICD implantation 54 vasodilators 54 pathological fractures 54 estimated glomerular filtration 54 antiarrhythmic drugs 54 biochemical recurrence 54 atherothrombosis 54 cTnI 54 NovoLog ® Mix 54 gout flares 54 Asymptomatic 54 lamotrigine 54 fasting triglyceride levels 54 nonfatal myocardial infarction MI 54 QRS interval 54 plasma lipid 54 Doxil ® 54 invasive candidiasis 54 impaired endothelial 54 endothelial activation 54 pioglitazone 54 5 Fluorouracil 54 KETEK 54 containing abacavir 54 nucleoside analog 54 endometrial carcinoma 54 Catheter Associated 54 acromegalic patients 54 highest tertile 54 foveal thickness 54 tachyarrhythmias 54 clinically meaningful differences 54 Interferon beta 1a 54 colesevelam HCl 54 ACE Inhibitor 54 candidemia 54 indapamide 54 Acute Ischemic Stroke 54 impaired renal 54 Lenalidomide 54 raloxifene Evista 54 non selective NSAIDs 54 angioplasty stenting 54 capillary leak 54 strong CYP#A# inducers 54 FGFR4 54 Heavy menstrual bleeding 54 overt hepatic encephalopathy HE 54 trastuzumab Herceptin ® 54 APTIVUS R 54 Hazard Ratio HR 54 metformin Glucophage 54 + PH# 54 AGILECT R 54 endometrial kidney 54 carbohydrate absorption 54 transaminase levels 54 dose clopidogrel 54 platelet inhibition 54 PREZISTA r 54 fatal IHD 54 hsCRP 54 EDARBI 53 pulmonary artery hypertension 53 Immunotherapeutic 53 carcinoids 53 morphometric vertebral fractures 53 Mimpara 53 cytopenias 53 systemic corticosteroids 53 antiplatelet 53 elevated transaminases 53 tenofovir emtricitabine 53 oral antidiabetes 53 receiving XGEVA 53 noncarriers 53 pharmacokinetic interactions 53 neutropaenia 53 incidence ≥ 53 thyrotropin 53 Thrombotic events 53 colorectal adenomas 53 CMV infection 53 EGFR TKIs 53 serum leptin 53 Triapine R 53 NNT = 53 TAXUS p value 53 hypoxemia 53 Bicalutamide 53 antithrombotic 53 chlorthalidone 53 biologic DMARDs 53 Anaphylactic reactions 53 systolic dysfunction 53 lipid lowering medication 53 FOLPI 53 International Normalized Ratio 53 CRBSI 53 obstructive CAD 53 T2DM 53 ritonavir boosted protease inhibitor 53 cTnT 53 ECG abnormalities 53 TOPAMAX ® 53 plasma homocysteine levels 53 antiplatelet therapy 53 Prospective Randomized 53 PegIFN RBV 53 REYATAZ r arm 53 platelet aggregation 53 serum potassium levels 53 adalimumab Humira 53 alanine aminotransferase 53 dronedarone 53 systemic corticosteroid 53 elevated CRP 53 hepatic function 53 antidepressants fluoxetine 53 MAO inhibitors 53 CYP #A# 53 CK MB 53 voriconazole 53 fibrate drugs 53 defibrillator CRT D 53 underwent percutaneous coronary 53 hepatic glucose production 53 Thromboembolism 53 acitretin 53 HbA1c levels 53 postmenopausal hormone replacement 53 BENICAR 53 recurrent genital herpes 53 ZOLINZA 53 drug eluting stent implantation 53 candesartan 53 drug depresses breathing 53 oral prednisolone 53 Cathy.Hales @ htimes.com 53 simvastatin #mg 53 Hb A1C 53 liposomal doxorubicin 53 vasomotor symptoms 53 Atacand 53 peginterferon alfa 2b 53 oral FTY# 53 carotid plaques 53 panitumumab Vectibix 53 comorbid conditions 53 gemifloxacin 53 Serious Infections 53 Mycophenolate mofetil 53 Hemorrhagic stroke 53 inotropes 53 symptom flare ups 53 activated partial thromboplastin 53 statin therapy 53 aPTT 53 ezetimibe simvastatin 53 intravitreal injections 53 AZOR 53 MADIT II 53 PDGFR 53 percutaneous transluminal coronary angioplasty 53 rosiglitazone maleate 53 conjugated equine estrogens 53 cilostazol 53 Anthracycline 53 Lantus insulin 53 SMZ TMP 53 thalidomide Thalomid 53 myelosuppressive chemotherapy 53 Tranexamic acid 53 multivariable adjustment 53 ug dose 53 cardiovascular hospitalization 53 eplerenone 53 dyslipidaemia 53 serum IGF 53 Trastuzumab 53 rabeprazole 53 intracranial stenosis 53 prolonged QT intervals 53 Free Survival PFS 53 antidiabetic medications 53 perioperative mortality 53 apneic 53 bypass graft CABG surgery 53 imipenem 53 serum LDL cholesterol 53 efalizumab 53 Disease ILD 53 System IPSS 53 cisplatin chemotherapy 53 B7 H3 53 EBRT 53 tranylcypromine 53 4mg/kg 53 LMWH 53 arterial thrombosis 53 AMEVIVE 53 fasting plasma 53 moderate hepatic impairment 53 pleiotropic 53 hyperoxia 53 Capecitabine 53 goserelin 53 #mg doses [002] 53 topical calcineurin inhibitors 53 Tumor Lysis Syndrome 53 Demonstrates Positive 53 clot formation 53 divalproex 53 pain palliation 53 debulking surgery 53 nitrotyrosine 53 NIDDM 53 vasodilatory 53 SPRYCEL ® 53 Gemzar ® 53 tenecteplase 53 CrCl 53 REVLIMID ® 53 beta carotene supplementation 53 Estradiol 53 ventricular arrhythmias 53 beclomethasone dipropionate 53 uncertainties materialize Shire plc 53 thrombolytic therapy 53 gestational hypertension 53 enalapril 53 creatine kinase CK 53 triglyceride lowering 53 coronary revascularisation 53 Percutaneous Coronary Intervention 53 glycoprotein IIb IIIa inhibitors 53 kidney urologic 53 dexrazoxane 53 peripheral sensory neuropathy 53 peri procedural 53 ivabradine 53 thiazolidinediones TZDs 53 plasma leptin 53 renoprotective 53 Hepatic Impairment 53 primary percutaneous coronary 53 corrected QT interval